Uhrlaß Silke, Verma Shyam B, Gräser Yvonne, Rezaei-Matehkolaei Ali, Hatami Maryam, Schaller Martin, Nenoff Pietro
Laboratory for Medical Microbiology, 04571 Rötha OT Mölbis, Germany.
Nirvan Skin Clinic, Vadodara 390020, Gujarat, India.
J Fungi (Basel). 2022 Jul 21;8(7):757. doi: 10.3390/jof8070757.
is a newly identified dermatophyte species that has been found in a near-epidemic form on the Indian subcontinent. There is evidence of its spread from the Indian subcontinent to a number of countries worldwide. The fungus is identical to genotype VIII within the species complex, which was described in 2019 by sequencing the Internal Transcribed Spacer (ITS) region of ribosomal DNA of the dermatophyte. More than 10 ITS genotypes of and can now be identified. causes inflammatory and itchy, often widespread, dermatophytosis affecting the groins, gluteal region, trunk, and face. Patients of all ages and genders are affected. The new species has largely displaced other previously prevalent dermatophytes on the Indian subcontinent. has become a problematic dermatophyte due to its predominantly in vitro genetic resistance to terbinafine owing to point mutations of the squalene epoxidase gene. It also displays in vivo resistance to terbinafine. The most efficacious drug currently available for this terbinafine-resistant dermatophytoses, based on sound evidence, is itraconazole.
是一种新发现的皮肤癣菌物种,已在印度次大陆以近乎流行的形式被发现。有证据表明它已从印度次大陆传播到世界上许多国家。该真菌与2019年通过对皮肤癣菌核糖体DNA的内部转录间隔区(ITS)进行测序描述的物种复合体中的基因型VIII相同。现在可以鉴定出超过10种和的ITS基因型。引起炎症性和瘙痒性、通常广泛分布的皮肤癣菌病,影响腹股沟、臀区、躯干和面部。所有年龄和性别的患者都会受到影响。这种新物种在很大程度上已取代了印度次大陆其他先前流行的皮肤癣菌。由于其角鲨烯环氧酶基因的点突变导致对特比萘芬主要具有体外遗传抗性,已成为一种有问题的皮肤癣菌。它在体内也显示出对特比萘芬的抗性。基于充分的证据,目前可用于这种对特比萘芬耐药的皮肤癣菌病的最有效药物是伊曲康唑。